Breaking News Instant updates and real-time market news.

SYY

Sysco

$68.41

-1.6 (-2.29%)

, PBH

Prestige Brands

$37.43

-0.25 (-0.66%)

20:25
08/12/18
08/12
20:25
08/12/18
20:25

Notable companies reporting before Monday's open

Notable companies reporting before Monday's open, with earnings consensus, include Sysco (SYY), consensus 93c... Prestige Brands (PBH), consensus 63c... Nine Energy Service (NINE), consensus 36c... NeoGenomics (NEO), consensus 2c.

SYY

Sysco

$68.41

-1.6 (-2.29%)

PBH

Prestige Brands

$37.43

-0.25 (-0.66%)

NINE

Nine Energy Services

$29.40

0.38 (1.31%)

NEO

NeoGenomics

$12.50

-0.56 (-4.29%)

  • 13

    Aug

  • 13

    Aug

  • 24

    Sep

  • 25

    Sep

  • 06

    Nov

SYY Sysco
$68.41

-1.6 (-2.29%)

08/10/18
08/10/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Intel (INTC) downgraded to Sell from Neutral at Goldman Sachs with analyst Toshiya Hari saying Intel's struggles with 10nm process technology makes the analyst incrementally more negative on the company's competitive positioning and margin outlook. 2. Booking Holdings (BKNG) downgraded to Neutral from Buy at Citi and UBS as well as Neutral from Overweight at JPMorgan. 3. Sysco (SYY) downgraded to Sell from Hold at Pivotal Research with analyst Ajay Jain saying he believes the move up in the stock over the past three months is inconsistent with growing industry headwinds as well as Sysco's company-specific issues. 4. Campbell Soup (CPB) downgraded to Underweight from Neutral at JPMorgan with analyst Ken Goldman saying he agrees with activist Third Point that Campbell's best option is to sell the company; however, he sees a sale as an unlikely outcome. 5. Redfin (RDFN) downgraded to Neutral from Buy at DA Davidson with analyst Tom White citing its Q2 results and below-consensus Q3 guidance. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
08/10/18
PIVT
08/10/18
DOWNGRADE
Target $58
PIVT
Sell
Sysco downgraded to Sell from Hold at Pivotal Research
Pivotal Research analyst Ajay Jain downgraded Sysco to Sell from Hold ahead of the company's Q4 earnings report scheduled for Monday, as he believes the move up in the stock over the past three months is inconsistent with growing industry headwinds as well as Sysco's company-specific issues. Jain maintains a $58 price target on Sysco shares.
07/18/18
WELS
07/18/18
NO CHANGE
Target $48
WELS
Outperform
US Foods price target raised to $48 from $42 at Wells Fargo
Wells Fargo analyst Edward Kelly raised his price target for US Foods (USFD) to $48 from $42 as his confidence in potential upside to his already above-consensus numbers is growing. The analyst believes the stock remains compelling as the combination of accelerating top and bottom-line performance in the coming quarters, potential upside to the company's three-year goals, a large longer-term self-help angle associated with the margin gap to Sysco (SYY), outsized leverage to M&A, and a discount valuation could all yield material upside to the stock. Kelly reiterates an Outperform rating on US Foods rating.
07/18/18
WELS
07/18/18
NO CHANGE
Target $80
WELS
Outperform
Sysco price target raised to $80 from $71 at Wells Fargo
Wells Fargo analyst Edward Kelly raised his price target for Sysco to $80 from $71, while reiterating an Outperform rating on the shares. While the analyst believes it looks to be nearing a fair valuation, he sees further upside potential as it compounds low double-digit earnings growth and sees modest multiple expansion closer to its recent peak. Kelly expects the combination of strong fundamental performance, potential for earnings upside, a high-quality balance sheet, and attractive dividend to cement its place as a blue-chip investment idea in consumer.
PBH Prestige Brands
$37.43

-0.25 (-0.66%)

02/05/18
KEYB
02/05/18
NO CHANGE
Target $43
KEYB
Overweight
Prestige Brands price target lowered to $43 from $54 at KeyBanc
KeyBanc analyst Jason Gere lowered his price target for Prestige Brands to $43 from $54 saying he views the setback in its growth story as disappointing, yet temporary, but sees the risk/reward as attractive post pullback. The analyst reiterates an Overweight rating on the shares.
02/20/18
WBLR
02/20/18
NO CHANGE
WBLR
Prestige Brands shares have been 'unduly punished,' says William Blair
After hosting investor meetings with management, William Blair analyst Jon Andersen says shares of Prestige Brands have been "unduly punished." Despite a "draconian pullback" in the stock, fiscal 2018 has been a "reasonable year" for Prestige, Andersen tells investors in a research note. The analyst expects to see "relative share price outperformance" over the next couple of years. His thesis remains that Prestige's core brand portfolio targeting the over-the-counter healthcare market and free cash flow productivity supports earnings growth in the upper single digits. He keeps an Outperform rating on the shares.
05/08/18
DADA
05/08/18
NO CHANGE
Target $33
DADA
Neutral
Prestige Brands price target lowered to $33 from $42 at DA Davidson
DA Davidson analyst Linda Bolton Weiser lowered her price target on Prestige Brands to $33 and kept her Neutral rating ahead of the company's Q4 earnings this week. Weiser says the outlook for FY19 gross margins may be even weaker than when she downgraded the stock in February because of freight and labor inflation. The analyst also expects Prestige Brands to invest more on advertising and promotion, increasing costs and weighing on profitability, as she lowers her FY19 and FY20 EPS forecasts by 13c to $2.95 and $3.12 respectively.
07/03/18
WBLR
07/03/18
NO CHANGE
WBLR
Outperform
Prestige Brands household cleaning sale a positive, says William Blair
William Blair analyst Jon Andersen views Prestige Brands' sale of its household cleaning segment for $69M in cash as a positive development. The transaction enables Prestige to solely focus on over-the-counter healthcare, a market with better demand underpinnings and brands positioned for profitable growth over the long term, Andersen tells investors in a research note. He keeps an Overweight rating on the shares.
NINE Nine Energy Services
$29.40

0.38 (1.31%)

05/15/18
FBCO
05/15/18
NO CHANGE
Target $36
FBCO
Outperform
Nine Energy Services price target raised to $36 from $29 at Credit Suisse
Credit Suisse analyst James Wicklund raised his price target for Nine Energy Services to $36 from $29 following quarterly results. The analyst reiterates an Outperform rating on the shares.
06/08/18
TUDR
06/08/18
DOWNGRADE
TUDR
Hold
Nine Energy Services downgraded to Hold from Buy at Tudor Pickering
06/13/18
RAJA
06/13/18
INITIATION
Target $40
RAJA
Strong Buy
Nine Energy Services initiated with a Strong Buy at Raymond James
Raymond James analyst Marshall Adkins initiated Nine Energy Services with a Strong Buy rating and $40 price target.
06/13/18
06/13/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Liberty Global (LBTYA) initiated with a Sell at Berenberg. 2. Emergent BioSolutions (EBS) initiated with a Buy at Argus. 3. Nine Energy Services (NINE) initiated with a Strong Buy at Raymond James. 4. Can-Fite BioPharma (CANF) assumed with a Buy at H.C. Wainwright. 5. Control4 (CTRL) initiated with a Buy at Roth Capital. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
NEO NeoGenomics
$12.50

-0.56 (-4.29%)

05/02/18
FANA
05/02/18
DOWNGRADE
Target $11
FANA
Equal-Weight
NeoGenomics downgraded to Equal-Weight from Overweight at First Analysis
First Analysis analyst Joseph Munda downgraded NeoGenomics to Equal-Weight citing valuation following the company's Q1 results. The analyst says NeoGenomics' fundamentals remain attractive. He has an $11 price target for the shares.
04/16/18
BTIG
04/16/18
UPGRADE
Target $11
BTIG
Buy
NeoGenomics upgraded to Buy at BTIG on solid volume trends and cost cuts
As reported earlier, BTIG analyst Sean Lavin upgraded NeoGenomics to Buy from Hold with a price target of $11. Lavin says the issues around exposure to Texas and Florida markets as well as lingering issues around Clarient have "largely dissipated". While the analyst remains concerned about the risk of "unexpected reimbursement changes", he adds that Medicare pricing for 2018 being in place cushions the risk around NeoGenomics guidance, while its growing Biopharma business and cost-cutting provide higher growth potential for the stock over time.
04/16/18
BTIG
04/16/18
UPGRADE
BTIG
Buy
NeoGenomics upgraded to Buy from Neutral at BTIG
11/30/17
GABE
11/30/17
NO CHANGE
GABE
Buy
NeoGenomics named a best idea for 2018 at Gabelli
Gabelli analyst Sara Wojda named NeoGenomics a best idea for 2018 citing double-digit volume growth combined with double-digit reduction in cost per test, contined share gains in the core clinical services division, and expectations for stabilization in pricing for FISH tests. Wojda rates NeoGenomics a Buy with a $12 PMV.

TODAY'S FREE FLY STORIES

LYV

Live Nation

$48.15

-0.53 (-1.09%)

17:46
08/17/18
08/17
17:46
08/17/18
17:46
Hot Stocks
Live Nation CFO discloses sale of 40K shares of common stock »

Live Nation CFO Elizabeth…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLE

Energy Select Sector SPDR

$72.63

0.21 (0.29%)

, XLU

Utilities SPDR

$54.50

0.25 (0.46%)

17:40
08/17/18
08/17
17:40
08/17/18
17:40
General news
Week ending ETF Scorecard: Consumer Staples outperforms, Energy skids »

S&P500 SECTORS:…

XLE

Energy Select Sector SPDR

$72.63

0.21 (0.29%)

XLU

Utilities SPDR

$54.50

0.25 (0.46%)

IYR

DJ US Real Estate Index Fund

$83.16

0.765 (0.93%)

XLP

Consumer Staples Sector SPDR

$55.02

0.39 (0.71%)

XLY

Consumer Discretionary Sector SPDR

$112.51

0.11 (0.10%)

XLB

S&P Select Materials SPDR

$58.41

0.41 (0.71%)

XLF

Financial Select Sector

$28.16

0.055 (0.20%)

XLV

Health Care Select Sector SPDR

$91.12

0.33 (0.36%)

XLK

Technology Select Sector SPDR

$73.17

0.14 (0.19%)

XLI

Industrial Select Sector SPDR

$76.26

0.47 (0.62%)

GLD

SPDR Gold Trust

$112.12

1.01 (0.91%)

SLV

iShares Silver Trust

$13.93

0.16 (1.16%)

USO

United States Oil Fund

$13.70

0.065 (0.48%)

UNG

United States Natural Gas Fund

$24.18

0.295 (1.24%)

HYG

iShares iBoxx $ High Yield Corporate Bond

$86.03

0.08 (0.09%)

LQD

iShares iBoxx $ Investment Grade Corporate Bond

$115.97

0.11 (0.09%)

TLT

iShares 20+ Year Treasury Bond Fund

$120.99

0.16 (0.13%)

IEF

iShares 7-10 Year Treasury Bond ETF

$102.49

0.04 (0.04%)

SHY

iShares 1-3 Year Treasury Bond

$83.28

0.03 (0.04%)

IWD

iShares Russell 1000 Value

$126.16

0.6 (0.48%)

IWF

iShares Russell 1000 Growth

$150.80

0.27 (0.18%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GLD

SPDR Gold Trust

$112.12

1.01 (0.91%)

17:33
08/17/18
08/17
17:33
08/17/18
17:33
Hot Stocks
SPDR Gold Trust holdings fall to 772.24MT from 773.41MT »

This is the 5th…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GDOT

Green Dot

$85.04

0.37 (0.44%)

17:30
08/17/18
08/17
17:30
08/17/18
17:30
Hot Stocks
Green Dot exec Dent sells 7,754 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

SMSI

Smith Micro

$2.49

-0.01 (-0.40%)

17:17
08/17/18
08/17
17:17
08/17/18
17:17
Syndicate
Breaking Syndicate news story on Smith Micro »

Smith Micro files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NDRA

ENDRA Life Sciences

$2.70

0.2 (8.00%)

17:14
08/17/18
08/17
17:14
08/17/18
17:14
Syndicate
Breaking Syndicate news story on ENDRA Life Sciences »

ENDRA Life Sciences files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BA

Boeing

$346.44

0.55 (0.16%)

17:10
08/17/18
08/17
17:10
08/17/18
17:10
Hot Stocks
Boeing awarded $152.5M U.S. Navy contract »

Boeing is awarded a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BA

Boeing

$346.44

0.55 (0.16%)

17:09
08/17/18
08/17
17:09
08/17/18
17:09
Hot Stocks
Boeing awarded $217M Defense Department contract »

The Boeing Co has been…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LLL

L3 Technologies

$210.37

0.56 (0.27%)

17:08
08/17/18
08/17
17:08
08/17/18
17:08
Hot Stocks
L3 Technologies awarded $240M Defense Department contract »

L-3 Communications was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HSGX

Histogenics

$2.65

-0.05 (-1.85%)

17:06
08/17/18
08/17
17:06
08/17/18
17:06
Syndicate
Breaking Syndicate news story on Histogenics »

Histogenics files $75M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PLD

Prologis

$67.45

1.79 (2.73%)

, DCT

DCT Industrial

$68.77

1.805 (2.70%)

16:58
08/17/18
08/17
16:58
08/17/18
16:58
Conference/Events
DCT Industrial to host special shareholder meeting »

Special Shareholder…

PLD

Prologis

$67.45

1.79 (2.73%)

DCT

DCT Industrial

$68.77

1.805 (2.70%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WLK

Westlake Chemical

$95.61

-1.33 (-1.37%)

16:56
08/17/18
08/17
16:56
08/17/18
16:56
Hot Stocks
Westlake Chemical expands share repurchase program by $150M »

The Board of Directors of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Sep

  • 11

    Sep

SM

SM Energy

$27.38

0.17 (0.62%)

16:55
08/17/18
08/17
16:55
08/17/18
16:55
Recommendations
SM Energy analyst commentary at MUFG »

SM Energy price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Aug

PENN

Penn National

$33.04

0.86 (2.67%)

16:51
08/17/18
08/17
16:51
08/17/18
16:51
Hot Stocks
Penn National CEO acquires 100,000 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FB

Facebook

$173.78

-0.98 (-0.56%)

16:49
08/17/18
08/17
16:49
08/17/18
16:49
Periodicals
U.S. wants Facebook to help wiretap Messenger for criminal probe, Reuters says »

The U.S. government is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

  • 22

    Aug

  • 06

    Sep

  • 18

    Sep

WLK

Westlake Chemical

$95.61

-1.33 (-1.37%)

16:46
08/17/18
08/17
16:46
08/17/18
16:46
Hot Stocks
Westlake Chemical raises quarterly dividend 19% to 25c per share »

The dividend will be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Sep

  • 11

    Sep

EAST

Eastside Distilling

$7.40

-0.01 (-0.13%)

16:45
08/17/18
08/17
16:45
08/17/18
16:45
Syndicate
Breaking Syndicate news story on Eastside Distilling »

Eastside Distilling files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LOV

Spark Networks

$12.80

-0.095 (-0.74%)

16:44
08/17/18
08/17
16:44
08/17/18
16:44
Syndicate
Spark Networks files to sell 515,416 ordinary shares for holders »

Including 222 ordinary…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AHPA

Avista Healthcare Public Acquisition Corp.

$10.12

(0.00%)

16:42
08/17/18
08/17
16:42
08/17/18
16:42
Hot Stocks
Avista Healthcare Public Acquisition Corp., Organogenesis announce combination »

Avista Healthcare Public…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TCF

TCF Financial

$25.84

0.17 (0.66%)

16:41
08/17/18
08/17
16:41
08/17/18
16:41
Hot Stocks
TCF Financial COO sells 77,725 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LGF.A

Lionsgate

$22.95

-0.11 (-0.48%)

16:38
08/17/18
08/17
16:38
08/17/18
16:38
Recommendations
Lionsgate analyst commentary at Barrington »

Lionsgate price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Sep

16:35
08/17/18
08/17
16:35
08/17/18
16:35
General news
Breaking General news story  »

Moody's cuts Turkey…

MSL

MidSouth Bancorp

$14.90

0.1 (0.68%)

16:32
08/17/18
08/17
16:32
08/17/18
16:32
Hot Stocks
MidSouth Bancorp says 'will carefully review' letter sent by Jacobs Asset Mgt. »

MidSouth Bancorp issued…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EME

EMCOR

$77.96

1.005 (1.31%)

16:31
08/17/18
08/17
16:31
08/17/18
16:31
Hot Stocks
Emcor CEO sells 23,434 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

16:30
08/17/18
08/17
16:30
08/17/18
16:30
Options
Preliminary option volume of 22.3M today »

Preliminary option volume…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.